Use of the veterinary drug xylazine is having a profound impact on the health of those who use illicit substances across the United States. Originally developed by the pharmaceutical company Bayer in 1962 as a large animal sedative containing a muscle relaxant with analgesic properties, xylazine…
These Prevention Research Briefs are part of a seven-issue series developed by the Prevention Technology Transfer Center (PTTC) Network Coordinating Office (NCO). They highlight current trends in substance use and their implications for the field of prevention.
Women and Opioid Use
Women’s use and misuse of substances create unique challenges, especially in treatment and recovery from opioids. Medical research on substance use by women, along with other health-related concerns, is largely lacking, especially research specific to women and their physiological differences…